Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD
NCT04560660Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Mar 2021; status: completed.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04560660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04560660.